Dravet syndrome

DNA strand
Biotech

Encoded deciphers pivotal path with phase 1/2 gene therapy data

Encoded linked its Dravet syndrome gene therapy to a 78% reduction in seizures, keeping the biotech on track to start a pivotal study next year.
Nick Paul Taylor Dec 5, 2025 12:45pm
Glowing puzzle piece fitting into puzzle

Biogen pays Stoke $165M, bagging Dravet drug to fire up pipeline

Feb 18, 2025 9:28am
workers

Encoded lays off 29% of staff to fund Dravet gene therapy trial

Feb 13, 2025 10:20am
Stop sign

Takeda axes epilepsy asset after FDA weighs in on data package

Jan 30, 2025 7:19am
free bird maze fly freedom

Stoke's Dravet syndrome med released of partial clinical hold

Aug 7, 2024 8:54am
dodge go around pylon arrow road block

Takeda takes $140M loss on failed epilepsy drug, touts FDA run

Jul 31, 2024 9:14am